Intelectin (IntL), a lectin that exists on the brush border membrane of the small intestine, plays a role in the innate immune response and also acts as a receptor for lactoferrin (LF), an iron-binding glycoprotein found in milk and other secretions. Similar to human LF (hLF), bovine LF (bLF) has been shown to induce proliferation and differentiation of human enterocytes and to modulate their cytokine productions. To evaluate the interaction between human IntL (hIntL) and bLF, recombinant hIntL (rhIntL) conjugated with a tag sequence was examined for its ligand-binding capacity by using microtiter plates coated with LF or other proteins. Interestingly, rhIntL showed higher binding for bLF than hLF. It also bound pepsin hydrolysate of bLF, but to a lower degree than native bLF. A very low binding of rhIntL was observed for bovine serum albumin or transferrin. These findings suggest that hIntL acts as a receptor for bLF and its digested fragments.
exists in lipid raft microdomains on the brush border membrane of the small intestine.
3) IntL plays a role in the innate immune response to infections 4) and also acts as an intestinal receptor for lactoferrin (LF), 5) an iron-binding glycoprotein found in milk and other secretions. 6, 7) IntL has been shown to mediate the uptake of LF and its bound iron by enterocytes. 3, 5) LF, a member of the transferrin family with molecular mass of about 80 kDa, is a component of milk, saliva, tears, airway mucus and secondary granule of neutrophils. 6, 7) LF has a wide range of biological functions, including antimicrobial activities against pathogens, 8) immuno-modulatory/ anti-inflammatory effects, 9) regulation of cell proliferation, 10) and intestinal iron absorption. 5) Similar to human LF (hLF), bovine LF (bLF) has been shown to induce proliferation and differentiation of human enterocytes 10) and to modulate their cytokine production. 11) Beneficial effects of orally administered bLF on infections and iron status have also been recently demonstrated in clinical trials in human adults and infants. [12] [13] [14] [15] It has been reported from an in vitro study that brush border membranes prepared from human fetal small intestine showed higher affinity to hLF compared to bLF. 16) Binding of IntL to LF has been demonstrated only in a combination of receptors and ligands of human origin. 5) An immunohistochemical study using pig and mouse small intestinal explants has suggested that uptake of hLF to enterocytes is mediated by mouse IntL.
3) As far as we know, there has been no report on the binding of human IntL (hIntL) to bLF.
The interaction between hIntL and bLF or its peptides may provide important information for better understanding of the receptor-mediated mechanism behind the in vitro effects of bLF on human enterocytes and in vivo effects of ingested bLF in humans. In the present study, we expressed the gene encoding hIntL conjugated with a tag sequence in Escherichia coli. The recombinant hIntL (rhIntL) in the inclusion bodies was isolated and refolded by the artificial chaperone method. The binding capacity of rhIntL to bLF and its digested fragments was examined by a binding assay using microtiter plates.
MATERIALS AND METHODS
hIntL Gene and Its Expression in E. coli The cDNA clone encoding hIntL (human intelectin-1, No. 6641180) was obtained from American Type Culture Collection (Manassas, VA, U.S.A.). The coding region of the hIntL gene without signal sequence of N-terminal 16 amino acids 5) was amplified from the cDNA clone as a template by polymerase chain reaction (PCR) using a primer pair of sense 5Ј-CCC CCG TCG ACT GGA GTA CAG ATG AGG CTA ATA CTT AC-3Ј and anti-sense 5Ј-AAA AAC CCG GGA CAA AAC TCT CAA CGA TAG AAT AGA AG-3Ј, and subcloned into a TA cloning vector (pCR-XL-TOPO, Invitrogen, Carlsbad, CA, U.S.A.). The plasmid was digested with SalI and EcoRI restriction enzymes and the fragment of hIntL gene was ligated into an expression vector with N-terminal histidine affinity tag (HAT) sequence (pHAT10, Clontech, Mountain View, CA, U.S.A.), which was digested with the same restriction enzymes. The resulting expression vector pHAT10-hIntL was confirmed over the entire coding region of hIntL and the tag by sequencing.
The expression vector pHAT10-hIntL was transformed into E. coli DH5a. The cells harboring the plasmid were cultured overnight in 100 ml of Luria-Bertani medium containing 50 mg/ml of ampicillin at 37°C. Isopropyl-D-thio-bgalactopyranoside (Invitrogen) was then added to give a concentration of 1 mmol/l to induce protein expression, and the cells were further cultured for 4 h. The cells were harvested by centrifugation at 3000ϫg for 10 min at 4°C, dispersed in 10 ml of 50 mmol/l sodium phosphate buffer, pH 7.0, containing 300 mmol/l NaCl, and disrupted by sonication. The cell lysate was centrifuged at 19000ϫg for 10 min at 4°C and the pellet was washed twice with 10 ml of 50 mmol/l sodium phosphate buffer, pH 7.0, containing 4% Triton X-100 and 300 mmol/l NaCl. The pellet was collected by centrifugation at 25000ϫg for 20 min at 4°C and washed twice with 20 ml of purified water. The pellet of inclusion bodies was collected by centrifugation at 25000ϫg for 20 min at 4°C.
Refolding of rhIntL The rhIntL in the isolated inclusion bodies was refolded by the artificial chaperone method using detergent and b-cyclodextrin.
17) Briefly, the inclusion bodies containing 2.4 mg of protein were solubilized with 1.0 ml of 40 mmol/l Tris-HCl buffer, pH 7.6, containing 6.75 mol/l urea and 40 mmol/l dithiothreitol. To the mixture was added 14 ml of 160 mmol/l Tris-HCl buffer, pH 7.6, containing 0.05% cetyltrimethylammonium bromide and 2 mmol/l DLcystine, and the mixture was allowed to stand for 1 h at room temperature (RT). To the mixture was then added 3.75 ml of 3% b-cyclodextrin solution followed by overnight standing at RT. The mixture was centrifuged at 12000ϫg for 15 min at RT. The buffer of the refolded rhIntL in the supernatant was exchanged for 25 mmol/l Tris-HCl, pH 7.6, containing 0.15 mmol/l NaCl and 0.05% Tween 20 and concentrated to a volume of 0.6 ml using a centrifugal filter unit (Millipore, Billerica, MA, U.S.A.). The concentrated solution of rhIntl contained a total protein amount of 72.6 mg. The protein content was determined by BCA protein assay kit (Pierce, Rockford, IL, U.S.A.) using bovine serum albumin (bSA) as a standard. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed according to the method of Laemmli.
18)
Binding Assay hLF was purified from human milk by the method of Sawatzki and Kubanek. 19) bLF was produced by Morinaga Milk Industry Co., Ltd. Pepsin hydrolysate of bLF (bLFH) was prepared by the method of Tomita et al. 20) 96-well microtiter plates (Maxisorp, Nunc) were coated with 100 ml of 5 mg/ml hLF, bLF, bLFH, bovine serum albumin (bSA, Sigma, St. Louis, MO, U.S.A.), or bovine transferrin (bTF, Sigma) in 20 mmol/l sodium carbonate buffer, pH 9.6, for 2 h at RT. The plates were washed four times with 25 mmol/l Tris-HCl, pH 7.6, containing 0.15 mmol/l NaCl, 0.05% Tween 20 and 5 mmol/l CaCl 2 (Tween-TBS), and blocked with 200 ml of Tween-TBS containing 1% bSA (blocking solution) for 1 h at 37°C. The plates were washed four times and incubated with 100 ml of 10 mg/ml rhIntL in blocking solution for 2 h at 37°C. As a control, blocking solution with or without equimolar (1.1 mg/ml) synthetic HAT peptide (MTMITPSLKDHLIHNVHKEEHAHAHNKIDDD-DKVD, Sigma) was used instead of the solution of rhIntL. The plates were washed four times and incubated with 100 ml of 2500-fold diluted rabbit antibodies against HAT peptide (Clontech) in blocking solution for 1 h at 37°C. The plates were washed four times and incubated with 100 ml of 1000-fold diluted alkaline phosphatase-conjugated antibodies against rabbit IgG (Pierce) in blocking solution for 1 h at 37°C. The plates were washed and developed with 100 ml of substrate for alkaline phosphatase (Pierce) for 20 min at 37°C and the absorbance at 405 nm was measured.
Silver Staining The amounts of proteins and peptides adsorbed to microtiter plates after coating were analyzed by silver staining as described by Root and Wang. 21) Briefly, microtiter plates were coated with 100 ml of 5 mg/ml hLF, bLF, bLFH, bSA, or bTF in 20 mmol/l sodium carbonate buffer, pH 9.6, for 2 h at RT as described above. The coating solution was removed and 100 ml of freshly prepared silver staining reagent containing 0.1% silver nitrate, 0.1% ammonium nitrate, 0.15% formaldehyde, 0.5% tungstosilicic acid, and 2.5% sodium carbonate was added to each well and absorbance at 405 nm was measured.
RESULTS AND DISCUSSION

Expression and Refolding of rhIntL
We analyzed the distribution of rhIntL in the soluble and precipitate fractions of the lysates of E. coli cells harboring the expression vector pHAT10-hIntL by immumoblotting using antibodies against HAT peptide. rhIntL was exclusively detected in the precipitate fraction, suggesting that rhIntL was expressed in the form of a denatured protein and packed into inclusion bodies (details not shown). Therefore, we tried to induce gene expression by the addition of isopropyl-D-thio-b-galactopyranoside into the culture medium for efficient accumulation of rhIntL into inclusion bodies and then refolded the rhIntL in the isolated inclusion bodies by the artificial chaperone method, in which small molecules such as b-cyclodextrin promote folding of the chemically denatured protein. 17) We used 2.4 mg of the isolated inclusion bodies as a starting material and obtained 72.6 mg of the solubilized protein as a final product, indicating that about 3% of the denatured protein was refolded. The final product of rhIntL gave a single band with molecular mass of about 37 kDa on SDS-PAGE (Fig. 1 ), in agreement with the molecular mass calculated from the amino acid sequence of hIntL 5) and HAT tag. In previous reports, both hInlL in fetal small intestine 5) and rhIntL expressed in cultured animal cells 2) were isolated as a glycosylated homotrimer with a molecular mass of about 120 kDa. Recently, mouse IntL has been purified from small intestine in a monomeric form with no glycan chains, 22) suggesting that IntL possesses ligand-binding capacity both in the forms of oligomer and monomer, and that its glycan chain is not necessary for the binding. The refolded rhIntL in the present study is likely to have been a monomer, for the reason that the refolding was performed in the presence of an excess amount of reducing agent.
Binding of rhIntL to hLF, bLF and Its Peptides Table  1 shows the results of the binding assay. Refolded rhIntL gave absorbance for hLF, indicating that the ligand-binding capacity of rhIntL for hLF was successfully restored by the artificial chaperone method. The ligand specificity of rhIntL was confirmed by its very low binding for bSA and bTF. In the control experiments, in which rhIntL was replaced with the synthetic HAT peptide or omitted from the solution, no significant absorbance was observed for LF. Interestingly, rhIntL gave a higher value for bLF than for hLF in the binding assay. Moreover, rhIntL also bound bLFH with a lower absorbance compared to native bLF, but higher compared to hLF. Table 1 also shows the results of silver staining of proteins adsorbed to the microtiter plates. Similar levels of adsorbed hLF, bLF, bLFH, and bSA, and a lower level of adsorbed bTF to microtiter plates were detected by silver staining. This result excludes the possibility that the difference in rhIntL binding reflected different amounts of ligand proteins adsorbed to the microtiter plates.
Structural and functional similarities have been reported for LFs of human and bovine origin. The primary structure of bLF is 69% identical to hLF. 23) In in vitro studies, both hLF and bLF had been shown to induce proliferation and differentiation of human enterocytes 10) and to modulate their cytokine production. 11) In human clinical studies, beneficial effects of orally administered bLF have been demonstrated on lower respiratory tract illness in formula-fed infants, 14) skin infections by fungi in adults, 12) chronic hepatitis C in adults, 13) and on iron metabolism in formula-fed infants 14) and pregnant women. 15) The contribution of immuno-modulatory properties besides direct antimicrobial actions has been suggested for the protective effects of ingested bLF against infections. 24) One possible mechanism for the protective effects is that bLF or its digested peptide fragments generated in the gastrointestinal tract would indirectly modulate the systemic immune system by affecting gut-associated lymphoid tissue. In mice, oral administration of bLF or bLFH was shown to enhance production of cytokines such as IL-18 in the epithelial cells of the small intestine and to increase the numbers of many types of immune cells in the small intestinal compartments. 25) Another possible mechanism is that peptide fragments of bLF would exhibit systemic effects after absorption into the circulatory system. In both mechanisms, receptor-mediated interaction of bLF or its peptide fragments to intestinal epithelial cells may play an important role in the initial step for the subsequent cellular processes. In this respect, IntL was reported to mediate the uptake of hLF by human enterocytes 5) and mouse small intestinal explants.
3)
The binding assay system in the present study detected the interaction between rhIntL and bLFH. Therefore, it is of interest to apply this assay system to the isolation of the peptide fragment of bLF containing the domain responsible for the interaction. Thus far, using size exclusion chromatography, we have not obtained an active fraction of bLFH. Further study is needed to improve the recovery of the active fragment.
Very recently, hIntL was also cloned as a transcript predominantly expressed in the human omental adipose tissue and named omentin. 26) Omentin, as a putative adipocytokine in a soluble form, has been shown to enhance glucose uptake by adipocytes in the presence of insulin. Omentin has been also shown to increase Akt phosphorylation in the adipocytes in the absence and presence of insulin, 26) suggesting that omentin/IntL itself induces signal transduction of the cells. Because LF endogenously exists in blood and its content is increased during infection, it is of interest to study the influence of LF on the adipocytokine activity of omentin/IntL. In the intestine, IntL has been detected in both soluble form 3) and brush border membrane bound form. 3, 5) The membrane bound form of IntL has been reported to be inserted through a glycosylphosphatidylinositol anchor 5) or accumulated to glycolipid enriched lipid raft microdomains through its lectin activity.
3) These membrane bound forms of IntL are thought to be responsible for mediating LF uptake by the enterocyte.
In the present study, we have demonstrated for the first time that rhIntL has the capacity to bind bLF and its peptide fragments. Our results suggest that bLF even after its digestion can access the human intestinal portal for hLF. Further studies focusing on the cellular processes such as receptormediated transport and signal transduction by the complex of IntL and bLF or its peptides should be conducted to improve our knowledge of the mechanism of action of ingested LF. 
